期刊
JOURNAL OF CONTROLLED RELEASE
卷 190, 期 -, 页码 424-439出版社
ELSEVIER
DOI: 10.1016/j.jconrel.2014.04.012
关键词
Bioreducible polymer; Gene; Cardiovascular disease; Diabetes; Oncolytic adenovirus; Targeting
资金
- NIH [HL065477, CA107070, DK07703, DK085075]
Most currently available cationic polymers have significant acute toxicity concerns such as cellular toxicity, aggregation of erythrocytes, and entrapment in the lung capillary bed, largely due to their poor biocompatibility and non-degradability under physiological conditions. To develop more intelligent polymers, disulfide bonds are introduced in the design of biodegradable polymers. Herein, the sustained innovations of biomimetic nano-sized constructs with bioreducible poly(disulfide amine)s demonstrate a viable clinical tool for the treatment of cardiovascular disease, anemia, diabetes, and cancer. (C) 2014 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据